| Literature DB >> 32243791 |
Dane Dickson1, Jennifer Johnson2, Raymond Bergan3, Rebecca Owens4, Vivek Subbiah5, Razelle Kurzrock6.
Abstract
Integrating precision diagnostics into personalized treatments requires understanding how biomarkers relate to clinical outcomes. Various clinical data collection methods exist, each with strengths and weaknesses. Interventional data are high quality but narrowly focused. Real-world data (RWD) provide broader information but with variable quality. Master protocols allow better efficiency in data collection. The master observational trial bridges the gap between interventional and retrospective RWD collection methods. To view this SnapShot, open or download the PDF.Entities:
Year: 2020 PMID: 32243791 DOI: 10.1016/j.cell.2020.02.032
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582